Abstract
The adenomatous polyposis coli (APC) tumor suppressor gene is mutationally inactivated in both familial and sporadic forms of colorectal cancers. In addition, hypermethylation of CpG islands in the upstream portion of APC, a potential alternative mechanism of tumor suppressor gene inactivation, has been described in colorectal cancer. Because a subset of both gastric and colorectal cancers display the CpG island methylator phenotype, we hypothesized that epigenetic inactivation of APC was likely to occur in at least some gastric cancers. APC exhibits two forms of transcripts from exons 1A and 1B in the stomach. Therefore, we investigated CpG island methylation in the sequences upstream of exons 1A and 1B, i.e., promoters 1A and 1B, respectively. We evaluated DNAs from 10 gastric cancer cell lines, 40 primary gastric cancers, and 40 matching non-cancerous gastric mucosae. Methylated alleles of promoter 1A were present in 10 (100%) of 10 gastric cancer cell lines, 33 (82.5%) of 40 primary gastric cancers, and 39 (97.5%) of 40 non-cancerous gastric mucosae. In contrast, promoter 1B was unmethylated in all of these same samples. APC transcripts from exon 1A were not expressed in nine of the 10 methylated gastric cancer cell lines, whereas APC transcripts were expressed from exon 1B. Thus, expression from a given promoter correlated well with its methylation status. We conclude that in contrast to the colon, methylation of promoter 1A is a normal event in the stomach; moreover, promoter 1B is protected from methylation in the stomach and thus probably does not participate in this form of epigenetic APC inactivation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, Zou TT, Abraham JM, Kong D, Smolinski KN, Shi YO, Rhyu MG, Powell SM, James SP, Wilson KT, Herman JG and Meltzer SJ. . 1999 Cancer Res. 59: 1090–1095.
Graff JR, Herman JG, Myohanen S, Baylin SB and Vertino PM. . 1997 J. Biol. Chem. 272: 22322–22329.
Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB. . 1996 Proc. Natl. Acad. Sci. USA 93: 9821–9826.
Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Wilson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA and Baylin SB. . 1998 Proc. Natl. Acad. Sci. USA 95: 6870–6875.
Hiltunen MO, Alhonen L, Koistinaho J, Myohanen S, Paakkonen M, Marin S, Kosma VM and Janne J. . 1997 Int. J. Cancer 70: 644–648.
Horii A, Nakatsuru S, Ichii S, Nagase H and Nakamura Y. . 1993 Hum. Mol. Genet. 2: 283–287.
Joslyn G, Carlson M, Thliveris A, Albertsen H, Gelbert L, Samowitz W, Groden J, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, LePaslier D, Abderrahin H, Cohen D, Leppert M and White R. . 1991 Cell 66: 601–613.
Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I and Nakamura Y. . 1991 Science 253: 661–665.
Kuismanen SA, Holmberg MT, Salovaara R, Schweizer P, Aaltonen LA, de La Chapelle A, Nystrom-Lahti M and Peltomaki P. . 1999 Proc. Natl. Acad. Sci. USA 96: 12661–12666.
Miyoshi Y, Ando H, Nagase H, Nishisho I, Horii A, Miki Y, Mori T, Utsunomiya J, Baba S, Petersen G, Hamilton SR, Kinzler KW, Vogelstein B and Nakamura Y. . 1992a Proc. Natl. Acad. Sci. USA 89: 4452–4456.
Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T and Nakamura Y. . 1992b Hum. Mol. Genet. 1: 229–233.
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW. . 1997 Science 275: 1787–1790.
Motoyama T, Hojo H and Watanabe H. . 1986 Acta. Pathol. Jpn. 36: 65–83.
Nishimura K, Yokozaki H, Haruma K, Kajiyama G and Tahara E. . 1995 Int. J. Oncology 7: 587–592.
Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S and Hedge P. . 1991 Science 253: 665–669.
Nishizuka S, Tamura G, Terashima M and Satodate R. . 1998 J. Pathol. 185: 38–43.
Ogasawara S, Maesawa C, Tamura G and Satodate R. . 1994 Virchows Arch. 424: 607–611.
Orford K, Crockett C, Jensen JP, Weissman AM and Byers SW. . 1997 J. Biol. Chem. 272: 24735–24738.
Oshima M, Sugiyama H, Kitagawa K and Taketo M. . 1993 Cancer Res. 53: 5589–5591.
Papkoff J, Rubinfeld B, Schryver B and Polakis P. . 1996 Mol. Cell. Biol. 16: 2128–2134.
Powell SM, Cummings OW, Mullen JA, Asghar A, Fuga G, Piva P, Minacci C, Megha T, Tosi P and Jackson CE. . 1996 Oncogene 12: 1953–1959.
Powell SM, Papadopoulos N, Kinzler KW, Smolinski KN and Meltzer SJ. . 1994 Gastroenterology 107: 1759–1763.
Rhyu MG, Park WS, Jung YJ, Choi SW and Meltzer SJ. . 1994 Gastroenterology 106: 1584–1588.
Sparks AB, Morin PJ, Vogelstein B and Kinzler KW. . 1998 Cancer Res. 58: 1130–1134.
Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y and Imai K. . 1999 Int. J. Cancer 83: 309–313.
Tamura G, Ogasawara S, Nishizuka S, Sakata K, Maesawa C, Suzuki Y, Terashima M, Saito K and Satodate R. . 1996 Cancer Res. 56: 612–615.
Tamura G, Yin J, Wang S, Fleisher AS, Zou TT, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T and Meltzer SJ. . 2000 J. Natl. Cancer Inst. 92: 569–573.
Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP. . 1999a Proc. Natl. Acad. Sci. USA 96: 8681–8686.
Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, Baylin SB and Issa JP. . 1999b Cancer Res. 59: 2307–2312.
Acknowledgements
This work was supported in part by a Grant-in-Aid for Cancer Research (No. 10-3) from the Ministry of Health and Welfare of Japan. This work was also supported in part by NIH grants CA85069, CA78843, CA77057, DK47717 and DK53620, and by the Medical Research Service, Department of Veterans Affairs.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tsuchiya, T., Tamura, G., Sato, K. et al. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 19, 3642–3646 (2000). https://doi.org/10.1038/sj.onc.1203704
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203704
Keywords
This article is cited by
-
Genetic Gastric Cancer Risk Syndromes
Current Treatment Options in Gastroenterology (2020)
-
Investigation of promoter methylation of FSCN1 gene and FSCN1 protein expression in differentiated thyroid carcinomas
Molecular Biology Reports (2020)
-
Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer
BMC Cancer (2017)
-
Gene-specific promoter methylation is associated with micronuclei frequency in urothelial cells from individuals exposed to organic solvents and paints
Journal of Exposure Science & Environmental Epidemiology (2016)
-
Chemotherapy induced microsatellite instability and loss of heterozygosity in chromosomes 2, 5, 10, and 17 in solid tumor patients
Cancer Cell International (2014)